Intervention in the Context of Development: Pathways Toward New Treatments

作者: Jeremy Veenstra-VanderWeele , Zachary Warren

DOI: 10.1038/NPP.2014.232

关键词: SchizophreniaMedicineContext (language use)PhenocopyIntervention (counseling)Rett syndromeAge of onsetPsychiatryAutism spectrum disorderPsychological interventionBioinformatics

摘要: Neuropsychiatric disorders vary substantially in age of onset but are best understood within the context neurodevelopment. Here, we review opportunities for intervention at critical points developmental trajectories. We begin by discussing potential to prevent neuropsychiatric disorders. Once symptoms emerge, a number interventions have been studied either before diagnosis can be made or shortly after diagnosis. Although some these helpful, few based upon an understanding pathophysiology, and most ameliorate rather than resolve symptoms. As such, next portion review, turn our discussion genetic syndromes that rare phenocopies common diagnoses such as autism spectrum disorder schizophrenia. Cellular animal models point specific regulatory signaling pathways. examples, findings from mouse Fragile X Rett treatments now being tested randomized clinical trials. Paralleling oncology, hope will move nonspecific, like chemotherapies thrown wide range tumor types, specific, protein kinase inhibitors target molecularly defined tumors. Some targeted later show benefit broader, yet array cancers. medications developed neurodevelopmental similarly help subgroups patients with disruptions overlapping The insights gleaned treatment development phenocopy may also teach us how test emerging environmental risk factors.

参考文章(114)
Shanthi Krishnaswami, Jeremy Veenstra-VanderWeele, Zachary Warren, Nila Sathe, Edwin Williamson, Brittany Peters, Rebecca Jerome, Rachel Aiello, Rebekah Travis, Melissa L McPheeters, Amy S Weitlauf, Therapies for Children With Autism Spectrum Disorders Agency for Healthcare Research and Quality (US). ,(2014)
Ruthie E. Amir, Ignatia B. Van den Veyver, Mimi Wan, Charles Q. Tran, Uta Francke, Huda Y. Zoghbi, Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics. ,vol. 23, pp. 185- 188 ,(1999) , 10.1038/13810
Connie Kasari, Ann Kaiser, Kelly Goods, Jennifer Nietfeld, Pamela Mathy, Rebecca Landa, Susan Murphy, Daniel Almirall, Communication Interventions for Minimally Verbal Children With Autism: A Sequential Multiple Assignment Randomized Trial Journal of the American Academy of Child & Adolescent Psychiatry. ,vol. 53, pp. 635- 646 ,(2014) , 10.1016/J.JAAC.2014.01.019
David J. Miklowitz, Christopher D. Schneck, Manpreet K. Singh, Dawn O. Taylor, Elizabeth L. George, Victoria E. Cosgrove, Meghan E. Howe, L. Miriam Dickinson, Judy Garber, Kiki D. Chang, Early Intervention for Symptomatic Youth at Risk for Bipolar Disorder: A Randomized Trial of Family-Focused Therapy Journal of the American Academy of Child and Adolescent Psychiatry. ,vol. 52, pp. 121- 131 ,(2013) , 10.1016/J.JAAC.2012.10.007
Darren J. Burgess, Technology: a CRISPR genome-editing tool. Nature Reviews Genetics. ,vol. 14, pp. 80- ,(2013) , 10.1038/NRG3409
Thomas Insel, Bruce Cuthbert, Marjorie Garvey, Robert Heinssen, Daniel S. Pine, Kevin Quinn, Charles Sanislow, Philip Wang, Research domain criteria (RDoC): toward a new classification framework for research on mental disorders American Journal of Psychiatry. ,vol. 167, pp. 748- 751 ,(2010) , 10.1176/APPI.AJP.2010.09091379
Rafael Flores, Yuki Hirota, Brian Armstrong, Akira Sawa, Toshifumi Tomoda, DISC1 regulates synaptic vesicle transport via a lithium-sensitive pathway Neuroscience Research. ,vol. 71, pp. 71- 77 ,(2011) , 10.1016/J.NEURES.2011.05.014
Michelle Goldsmith, Manpreet Singh, Kiki Chang, Antidepressants and psychostimulants in pediatric populations: is there an association with mania? Pediatric Drugs. ,vol. 13, pp. 225- 243 ,(2011) , 10.2165/11591660-000000000-00000
Stephanie C Dulawa, Kerri A Holick, Brigitta Gundersen, Rene Hen, Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology. ,vol. 29, pp. 1321- 1330 ,(2004) , 10.1038/SJ.NPP.1300433